Omigapil

DB12879InvestigationalSmall molecule

Omigapil has been used in trials studying the treatment of Congenital Muscular Dystrophy.

Chemical structure of Omigapil
Formula / weight
C19H17NO · 275.3444 g/mol (avg)
Code names
CGP-3466B · TCH-346

Resolves to

Compound
UNII5V14HD0N4QCAS181296-84-4ChEMBLCHEMBL1232111ChEBI41778PubChem6419718
Structure
InChIKeyQLMMOGWZCFQAPU-UHFFFAOYSA-NSMILESCN(CC#C)CC1=CC2=CC=CC=C2OC2=CC=CC=C12
Targets
P04406GAPDH

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Omigapil, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In